Millennium Management
DRUG

Millennium Management’s Bright Minds Biosciences DRUG Stock Holding History

Millennium Management’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.86M Sell
52,832
-141,605
-73% -$11.4M ﹤0.01% 3231
2025
Q4 		$15.2M Buy
194,437
+117,756
+154% +$7.87M 0.01% 1828
2025
Q3 		$4.65M Sell
76,681
-34,690
-31% -$1.35M ﹤0.01% 3216
2025
Q2 		$2.91M Sell
111,371
-81,186
-42% -$2.43M ﹤0.01% 3533
2025
Q1 		$6.95M Buy
192,557
+152,178
+377% +$5.57M ﹤0.01% 2542
2024
Q4 		$1.45M Buy
+40,379
New +$1.42M ﹤0.01% 3886

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management's DRUG Position: Q1 2026 in Review

Millennium Management reduced its Bright Minds Biosciences (DRUG) stake by 73% in Q1 2026, selling an estimated $11.4M and leaving 52,832 shares worth $3.86M. The position accounts for ﹤0.01% of the portfolio, ranked #3231.

Millennium Management first reported a position in DRUG in Q4 2024 and has held it in 6 quarters since. The position peaked at $15.2M in Q4 2025. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Millennium Management held 52,832 shares of Bright Minds Biosciences worth $3.86M as of Q1 2026.
  • Millennium Management sold 141,605 Bright Minds Biosciences shares in Q1 2026, an estimated $11.4M.
  • Bright Minds Biosciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3231 holding.
  • Millennium Management first reported a position in Bright Minds Biosciences in Q4 2024 and has held it in 6 quarters since.
  • Millennium Management's Bright Minds Biosciences position peaked at $15.2M in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.